Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Xiaoxiang Du"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
As the validated agent for the treatment of chronic myelogenous leukemia (CML), flumatinib is a novel oral tyrosine kinase inhibitor (TKI) with higher potency and selectivity for BCR-ABL1 kinase compared to imatinib. Many patients experience aspergil
Externí odkaz:
https://doaj.org/article/2b20fbd654ce4770919ac3aa1ca0d47c
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundGround glass nodules (GGN) of the lung may be a precursor of lung cancer and have received increasing attention in recent years with the popularity of low-dose high-resolution computed tomography (CT). Many studies have discussed imaging fe
Externí odkaz:
https://doaj.org/article/618a57711ed946b8afb9dd43b50a64db
Publikováno v:
Arabian Journal of Chemistry, Vol 15, Iss 1, Pp 103514- (2022)
The main objective of our current study is to develop and validate an accurate and direct ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method to simultaneously detect plasma concentrations of tofacitinib and its metab
Externí odkaz:
https://doaj.org/article/f0c08f5ea219409396b6d0a190807c40
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
The contribution of the metabolites of linezolid to the associated myelosuppression is unknown in patients who are renal impairment. In this research, the purpose of our experiment was to explore and develop a quick and robust ultra performance liqui
Externí odkaz:
https://doaj.org/article/19219786efeb47bfbe12def20d7b29bb
Publikováno v:
Bulletin of Engineering Geology and the Environment. 81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3fb359358b685928a91dfeb6fcb52c0e
https://doi.org/10.1007/s10064-022-02647-6
https://doi.org/10.1007/s10064-022-02647-6
Publikováno v:
Arabian Journal of Chemistry, Vol 15, Iss 1, Pp 103514-(2022)
The main objective of our current study is to develop and validate an accurate and direct ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method to simultaneously detect plasma concentrations of tofacitinib and its metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9172741e4c9bc06937e6769176e196f
http://www.sciencedirect.com/science/article/pii/S1878535221005293
http://www.sciencedirect.com/science/article/pii/S1878535221005293
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 187
Duvelisib, a new oral phosphoinositide-3-kinase (PI3K)-δ and PI3K-γ inhibitor, was recently approved in the USA as the therapeutic drug for patients with the diseases of relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocyti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca8516d9037582703c6de5d87ead47ab
https://pubmed.ncbi.nlm.nih.gov/32442869
https://pubmed.ncbi.nlm.nih.gov/32442869
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 177:112850
In the present study, an accurate and sensitive ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method for the determination of plasma talazoparib concentration in rats was developed and established. The purpose of chrom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ef488cba2cb788dcddabf447b5deda
https://doi.org/10.1016/j.jpba.2019.112850
https://doi.org/10.1016/j.jpba.2019.112850
Publikováno v:
Pharmaceutical Biology. 53:995-1001
Kanglaite (KLT) is an oily substance extracted from Coix lacryma-jobi Linn. (Cramineae) and has been proved to significantly improve the life span and quality of life of patients, when combined with chemotherapy, radiotherapy, or surgery.The purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e50c9ef261659faf4dd52a921fbc5df
https://doi.org/10.3109/13880209.2014.952833
https://doi.org/10.3109/13880209.2014.952833
Publikováno v:
Pakistan journal of pharmaceutical sciences. 26(4)
A "cocktail"of numerous probe drugs to assess the metabolic activity of the corresponding cytochrome P450 enzymes requires that there is no problem of interaction among them. Some interactions among probe drugs can appear and may affect the rate of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cfaca4c81cd1ed48bece3db7b7f782ef
https://pubmed.ncbi.nlm.nih.gov/23811463
https://pubmed.ncbi.nlm.nih.gov/23811463